Ask about how long the symptoms have lasted, what treatments have been tried, if these symptoms interfere with their quality of life, and if anything alleviates any of these symptoms
Luchini A, Heenan RK, Paduano L, Vitiello G
Whether patients will tolerate daily dosing and strict timing requirements, and whether they will continue treatment long enough to see meaningful results, are important considerations for individual treatment planning
Physiological functions of carnitine and carnitine transporters in the central nervous system 4, 6
A total of 9340 participants with a high CV risk, who were 50 years of age, with HbA1c 7% were randomly assigned to receive placebo or liraglutide (1.8 mg)
Cpt1a-mediated fat oxidation, mechanisms, and therapeutic potential